분당서울대학교병원에 찾아오시는 길입니다.
우)13620, 경기도 성남시 분당구 구미로173번길 82
분당서울대학교병원의 공지사항을 알려드립니다.
다양하고 유익한 건강상식을 제공해 드립니다.
진료시간표
요일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
오전 | ||||||
오후 |
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cancer Res Treat
2022 ;54 (2) :424 -433
Minsu Kang, Hee Young Na, Soomin Ahn, Ji-Won Kim, Sejoon Lee, Soyeon Ahn, Ju Hyun Lee, Jeonghwan Youk, Haesook T Kim, Kui-Jin Kim, Koung Jin Suh, Jun Suh Lee, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Yoo-Seok Yoon, Jee Hyun Kim, Jin-Haeng Chung, Ho-Seong Han, Jong Seok Lee
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.
Elife
2022 ;11
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients.
Cancer Res Treat
2022 ;54 (2) :621 -629
Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-Un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer.
Cancer Res Treat
2022 ;54 (2) :488 -496
Jwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, Su-Jin Koh, Yongchel Ahn, Kyung Hae Jung, Jin-Hee Ahn, Sung-Bae Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Jae Ho Jeong, Hwa Jung Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Young Joo Min, Jin Ho Baek, Sook Ryun Park
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
Cancer Med
2022 ;11 (3) :705 -714
Minsu Kang, Koung Jin Suh, Ji-Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study.
PLoS One
2022 ;17 (1) :e0261671 -e0261671
Ji Yun Lee, Ju-Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang
Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based study.
Thromb Res
2022 ;213 :114 -118
Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S Mok, Se-Hoon Lee
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
J Clin Oncol
2022 ;40 (17) :1916 -1928
Yu Jung Kim, Seok Joon Yoon, Sang-Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of clinician prediction of survival in oncology outpatients with advanced cancer.
PLoS One
2022 ;17 (4) :e0267467 -e0267467
Yusuke Hiratsuka, Yu Jung Kim, Sang-Yeon Suh, Seon Hye Won, Sung Eun Choi, Thomas W LeBlanc, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee
The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer.
Ann Palliat Med
2022 ;11 (7) :2338 -2348
Hee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, Min Hwan Kim, Jae Ho Jeong, Ji-Yeon Kim, Dae-Won Lee, Jin-Hee Ahn, Heejung Chae, Kyung-Hun Lee, Jee Hyun Kim, Keun Seok Lee, Joo Hyuk Sohn, Yoon-La Choi, Seock-Ah Im, Kyung Hae Jung, Yeon Hee Park
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol
2022 ;8 (9) :1271 -1277
Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Heechul Shin, Eunyoung Kang, Eun-Kyu Kim, Sejoon Lee, Ji Won Woo, Hee Young Na, Soomin Ahn, Bum-Sup Jang, In Ah Kim, So Yeon Park, Jee Hyun Kim
Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data.
J Breast Cancer
2022 ;25 (5) :366 -378
Eun Hee Jung, Si Won Lee, Yu Jung Kim, Beodeul Kang, Koung Jin Suh, Ju Hyun Lee, Esther Jeon, Dahee Kim, Sung Soun Hur, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Eduardo Bruera
Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center.
JCO Oncol Pract
2022 ;18 (10) :e1661 -e1671
Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Koung Jin Suh, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, Jae Ho Byun, Jin Hyun Park, Gyeong-Won Lee, Keun Seok Lee, Joohyuk Sohn, Kyung Hae Jung, In Hae Park
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B).
Breast
2022 ;65 (0) :172 -178
Song Yi Park, Koung Jin Suh, Dae-Won Lee, Han Suk Ryu, Miso Kim, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Jee Hyun Kim, In Ae Park, Seock-Ah Im
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy.
Breast Cancer Res Treat
2022 ;196 (1) :121 -128
Hye In Lee, Min Kyoung Kang, Kihwan Hwang, Chae-Yong Kim, Yu Jung Kim, Koung Jin Suh, Byung Se Choi, Gheeyoung Choe, In Ah Kim, Bum-Sup Jang
Volumetric changes in gray matter after radiotherapy detected with longitudinal magnetic resonance imaging in glioma patients.
Radiother Oncol
2022 ;176 (0) :157 -164
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Seon-Hye Won, Eun Hee Jung, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study.
Ann Palliat Med
2022 ;11 (10) :3171 -3180
Jin Won Kim, Kyung-Hun Lee, Ji-Won Kim, Koung Jin Suh, Ah-Rong Nam, Ju-Hee Bang, Mei Hua Jin, Kyoung-Seok Oh, Jae-Min Kim, Tae-Yong Kim, Do-Youn Oh
The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancer.
Liver Int
2021 ;41 (2) :388 -395
Ji Yun Lee, Minsu Kang, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Kyoung-Ho Song, Eu Suk Kim, Hong Bin Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Mycoses
2021 ;64 (1) :60 -65
Eun Hee Jung, Hee Ryeong Jang, Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Ju-Hyun Lee, Jin-Haeng Chung, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Thorac Cancer
2021 ;12 (5) :619 -630
Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Sci Rep
2021 ;11 (1) :2514 -2514
Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy.
J Geriatr Oncol
2021 ;12 (6) :922 -929
Minsu Kang, Changhee Park, Se Hyun Kim, Sock Won Yoon, Koung Jin Suh, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Transl Lung Cancer Res
2021 ;10 (2) :699 -711
Koung Jin Suh, Jin Won Kim, Ji Eun Kim, Ji Hea Sung, Jiwon Koh, Kui-Jin Kim, Ji-Won Kim, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee, Keun-Wook Lee
Correlation between tumor infiltrating immune cells and peripheral regulatory T cell determined using methylation analyses and its prognostic significance in resected gastric cancer.
PLoS One
2021 ;16 (6) :e0252480 -e0252480
In Sil Choi, Ki Hwan Kim, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Hyun Park, Yu Jung Kim, Jin-Soo Kim, Jee Hyun Kim, Jin Won Kim
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.
Eur J Cancer
2021 ;154 :288 -295
Kyung-Hwak Yoon, Yeshong Park, Eunyoung Kang, Eun-Kyu Kim, Jee Hyun Kim, Se Hyun Kim, Koung Jin Suh, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Hee-Chul Shin
Effect of Estrogen Receptor Expression Level and Hormonal Therapy on Prognosis of Early Breast Cancer.
Cancer Res Treat
2021
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience.
Blood Res
2021 ;56 (4) :285 -292
Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee
Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.
Sci Rep
2021 ;11 (1) :23803 -23803
Hyun Jung Lee, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells.
Cancers (Basel)
2020 ;12 (9)
Ahrum Min, Kwangsoo Kim, Kyeonghun Jeong, Seongmin Choi, Seongyeong Kim, Koung Jin Suh, Kyung-Hun Lee, Sun Kim, Seock-Ah Im
Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.
Sci Rep
2020 ;10 (1) :12506 -12506
Se Hyun Kim, Soomin Ahn, Koung Jin Suh, Yu Jung Kim, So Yeon Park, Eunyoung Kang, Eun-Kyu Kim, In Ah Kim, Sumin Chae, Murim Choi, Jee Hyun Kim
Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Breast Cancer Res Treat
2020 ;183 (3) :697 -704
Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Hark Kyun Kim, Keun-Wook Lee
PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer.
Sci Rep
2020 ;10 (1) :12308 -12308
Yaewon Yang, Ahrum Min, Kyung-Hun Lee, Han Suk Ryu, Tae-Yong Kim, Go-Un Woo, Koung Jin Suh, Dae-Won Lee, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
J Breast Cancer
2020 ;23 (2) :182 -193
Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee
Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases.
J Cancer Res Clin Oncol
2020 ;146 (9) :2399 -2410
Ja Min Byun, Jeong-Ok Lee, Koung Jin Suh, Jiyun Lee, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Soo-Mee Bang, Inho Kim, Sung-Soo Yoon
The Role of Anthracyclines in Acute Myeloid Leukemia Consolidation.
Anticancer Res
2020 ;40 (1) :357 -366
Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, Song Mi Moon, Koung Jin Suh, Dae-Won Lee, Chan-Young Ock, Miso Kim, Yunhee Choi, Yoojoo Lim, Kyung-Hun Lee, Se Hyun Kim, Tae Min Kim, Tae-Yong Kim, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Jong Seok Lee, Eu Suk Kim, Hong Bin Kim, Nam-Joong Kim, Yu Jung Kim, Wan Beom Park, Myoung-Don Oh
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Clin Infect Dis
2020 ;71 (2) :422 -425
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
PLOS ONE
2018 ;13 (10)
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
INT J MOL SCI
2018 ;19 (10)
Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response
MOL CANCER THER
2018 ;17 (12) :2507 -2518
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
PLOS ONE
2018 ;13 (6)
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
CANCER IMMUNOL IMMUN
2018 ;67 (3) :459 -470
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy
EUR J NUCL MED MOL I
2018 ;45 (3) :328 -339
번호 | 매체명 | 제목 | 발간일 |
---|---|---|---|
13 | 청년의사 | 개인 맞춤형 항암 치료 방향 보여준 'ASCO 2022' | 2022-06-16 |
12 | 헬스인뉴스 | "'항제-약물결합체'가 항암치료의 중요한 한 축 될 것" | 2022-06-16 |
11 | 약사공론 | "개인 맞춤형 항암 치료의 시대 포문 열 것" | 2022-06-15 |
10 | 메디게이트뉴스 | 대한항암요법연구회, ASCO 2022 분석해 암 치료 최신 지견 공유 | 2022-06-15 |
9 | 약업신문 | 항암요법연구회, "개인 맞추혐 항함 치료 시대 포문 열 것" | 2022-06-15 |
8 | 의학신문 | 2022 ASCO 정밀의료와 개인 맞춤형 치료 시대 '집중" | 2022-06-15 |
7 | 의사신문 | 항암요법연구회 "맞춤형 항암 치료 시대 포문 열 것" | 2022-06-15 |
6 | 헬스조선 | 면역항암제, 폐암·신장암에도 효과… 수술 재발률 감소시켜 | 2021-06-23 |
5 | 의료정보 | HER2 양성 표적치료제, 폐암 비롯 대장암·담도암도 효과 확인 | 2021-06-22 |
4 | 청년의사 | 국내 암 전문가들이 주목한 ASCO2021 연구는? | 2021-06-22 |